PULMATRIX, INC. Accrued Salaries, Current
PULMATRIX, INC. (PULM) had Accrued Salaries, Current of $37.00 thousand as of 2025-09-30, per its 10-Q filed 2025-10-16.
Financial Statements › Notes › Payables and Accruals › Accrued Liabilities, Current
us-gaap:AccruedSalariesCurrent · last filed 2025-10-16
- 2025-09-30: Accrued Salaries, Current $37.00K.
- 2024-12-31: Accrued Salaries, Current $38.00K.
- 2022-09-30: Accrued Salaries, Current $960.00K.
- 2022-06-30: Accrued Salaries, Current $604.00K.
| Period end | Accrued Salaries, Current | Accrued Salaries, Current as first filed |
|---|---|---|
| 2025-09-30 | $37.00K 10-Q · filed 2025-10-16 | |
| 2024-12-31 | $38.00K 10-Q · filed 2025-10-16 | |
| 2022-09-30 | $960.00K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $604.00K 10-Q · filed 2022-08-10 | |
| 2022-03-31 | $290.00K 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $1.05M 10-Q · filed 2022-11-10 | $991.00K 10-K · filed 2022-03-29 |
| 2021-09-30 | $692.00K 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $409.00K 10-Q · filed 2021-08-10 | |
| 2021-03-31 | $197.00K 10-Q · filed 2021-05-11 | |
| 2020-12-31 | $813.00K 10-K · filed 2022-03-29 | |
| 2020-09-30 | $898.00K 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $476.00K 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $294.00K 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $527.00K 10-K · filed 2021-03-23 | |
| 2019-09-30 | $582.00K 10-Q · filed 2019-11-01 | |
| 2019-06-30 | $369.00K 10-Q · filed 2019-08-05 | |
| 2019-03-31 | $1.13M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $915.00K 10-K · filed 2020-03-26 | |
| 2018-09-30 | $1.23M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $1.08M 10-Q · filed 2018-08-03 | |
| 2018-03-31 | $1.12M 10-Q · filed 2018-05-11 | |
| 2017-12-31 | $1.11M 10-K · filed 2019-02-19 | |
| 2017-09-30 | $646.00K 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $517.00K 10-Q · filed 2017-08-04 | |
| 2017-03-31 | $870.00K 10-Q · filed 2017-05-05 | |
| 2016-12-31 | $796.00K 10-K · filed 2018-03-13 | |
| 2016-09-30 | $583.00K 10-Q · filed 2016-11-04 | |
| 2016-06-30 | $456.00K 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $226.00K 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $673.00K 10-K · filed 2017-03-10 | |
| 2015-09-30 | $432.00K 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $312.00K 10-Q · filed 2015-08-14 | |
| 2014-12-31 | $60.00K 10-K · filed 2016-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |